1. Home
  2. VC vs MLYS Comparison

VC vs MLYS Comparison

Compare VC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$96.83

Market Cap

3.2B

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$37.27

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
MLYS
Founded
2000
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.1B
IPO Year
2000
2023

Fundamental Metrics

Financial Performance
Metric
VC
MLYS
Price
$96.83
$37.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
7
Target Price
$129.08
$47.33
AVG Volume (30 Days)
377.6K
1.5M
Earning Date
10-23-2025
02-11-2026
Dividend Yield
1.13%
N/A
EPS Growth
N/A
N/A
EPS
11.17
N/A
Revenue
$3,759,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.92
N/A
P/E Ratio
$8.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$65.10
$8.24
52 Week High
$129.10
$47.65

Technical Indicators

Market Signals
Indicator
VC
MLYS
Relative Strength Index (RSI) 34.06 44.07
Support Level $95.99 $36.50
Resistance Level $105.93 $38.23
Average True Range (ATR) 2.41 1.68
MACD -0.26 0.11
Stochastic Oscillator 9.66 47.55

Price Performance

Historical Comparison
VC
MLYS

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: